Home
>
National Drug Code (NDC)
>
Apidra
Apidra - 0088-2500-33 - (insulin glulisine)
Drug Information of Apidra
| Product NDC: | 0088-2500 |
| Proprietary Name: | Apidra |
| Non Proprietary Name: | insulin glulisine |
| Active Ingredient(s): | 100 [iU]/mL & nbsp; insulin glulisine |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Apidra
| Product NDC: | 0088-2500 |
| Labeler Name: | Sanofi-Aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021629 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090224 |
Package Information of Apidra
| Package NDC: | 0088-2500-33 |
| Package Description: | 10 mL in 1 VIAL, GLASS (0088-2500-33) |
NDC Information of Apidra
| NDC Code | 0088-2500-33 |
| Proprietary Name | Apidra |
| Package Description | 10 mL in 1 VIAL, GLASS (0088-2500-33) |
| Product NDC | 0088-2500 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | insulin glulisine |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20090224 |
| Marketing Category Name | NDA |
| Labeler Name | Sanofi-Aventis U.S. LLC |
| Substance Name | INSULIN GLULISINE |
| Strength Number | 100 |
| Strength Unit | [iU]/mL |
| Pharmaceutical Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
